(Q36402620)

14 August 2017

title

Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment (English)

1 reference

14 August 2017

1 reference

1 reference

Dennis A Revicki

1

1 reference

14 August 2017

Miriam Kimel

2

1 reference

14 August 2017

Kathy Beusterien

3

1 reference

14 August 2017

Jackie W Kwong

4

1 reference

14 August 2017

Julie A Varner

5

1 reference

14 August 2017

Michael H Ames

6

1 reference

14 August 2017

Sunny Mahajan

7

1 reference

14 August 2017

Roger K Cady

8

1 reference

14 August 2017

publication date

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

46

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

240-252

1 reference

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Migraine's impact today. Burden of illness, patterns of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

What do patients with migraine want from acute migraine treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Patient treatment preferences and the 5-HT1B/1D agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Determinants of patient satisfaction with migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Migraine therapy: development and testing of a patient preference questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Validation of the Patient Perception of Migraine Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Patient assessment of treatment satisfaction: methods and practical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Recommendations for evaluating the validity of quality of life claims for labeling and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Recommendations on health-related quality of life research to support labeling and promotional claims in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Migraine in the United States: epidemiology and patterns of health care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Variation in migraine prevalence by race.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00289.X

10.1111/J.1526-4610.2006.00289.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference